DNA methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden
BackgroundImmune checkpoint inhibitor (ICI) therapy has proven to be a promising treatment for colorectal cancer (CRC). We aim to investigate the relationship between DNA methylation and tumor mutation burden (TMB) by integrating genomic and epigenetic profiles to precisely identify clinical benefit...
Main Authors: | Hao Huang, Weifan Cao, Zhiping Long, Lei Kuang, Xi Li, Yifei Feng, Yuying Wu, Yang Zhao, Yinggang Chen, Peng Sun, Panxin Peng, Jinli Zhang, Lijun Yuan, Tianze Li, Huifang Hu, Gairui Li, Longkun Yang, Xing Zhang, Fulan Hu, Xizhuo Sun, Dongsheng Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1030335/full |
Similar Items
-
The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer
by: Yaxiong Zhang, et al.
Published: (2019-04-01) -
Combined ARHGEF6 and Tumor Mutational Burden may serve as a potential biomarker for immunotherapy of lung adenocarcinoma
by: Li Tong, et al.
Published: (2023-08-01) -
Biological Pathway-Derived TMB Robustly Predicts the Outcome of Immune Checkpoint Blockade Therapy
by: Ya-Ru Miao, et al.
Published: (2022-09-01) -
Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
by: Wenjie Li, et al.
Published: (2022-02-01) -
Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers
by: Timothy V. Pham, et al.
Published: (2021-10-01)